Alchemab
The Senior Director, Business Development leads the identification, evaluation, and execution of strategic partnerships to maximize the value of the company's therapeutic pipeline and discovery platform. This outward-facing role serves as the primary representative to pharmaceutical partners, building a structured partnering function and positioning the company as a partner of choice. The position also involves supporting the Chief Business Officer and leadership team on corporate strategy and financing initiatives.
Headquarters
London, England, United Kingdom
Company Size
51-200 employees
Founded
2019
Alchemab Therapeutics is a biotechnology company harnessing the power of the adaptive immune system to develop next-generation antibody therapeutics for hard-to-treat diseases. Their unique approach identifies resilient individuals — such as long-term cancer survivors — and uses leading-edge science and deep learning to create therapeutics from antibodies shared across those resilient populations. The company is advancing its pipeline into clinical trials, including a Phase 1 trial of ATLX-1282, and actively seeks biopharma partnerships.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Alchemab.
Alchemab didn’t post a salary, so this is our estimate from similar listings.
Business Development & In-Licensing Director
Scope Group
Senior Manager, Business Development
GSK plc
Director, Business Development
Rhodes Pharmaceuticals
Associate Director, M&A and Strategic Development
Hanwha Renewables
Blackstone Credit & Insurance – Structuring, Senior Associate
Blackstone
Vice President, Corporate Development & Innovation (18-Month Contract)
BCAA